News

Categories
Sign up
Featured Posts
Archive
Follow Us
  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon

Israeli medical device maker Alpha Tau raises $26 million to fund trials

JERUSALEM (Reuters) - Israeli medical device maker Alpha Tau Medical said on Thursday it raised $26 million in a funding round from investors including Shavit Capital, Medison Ventures and OurCrowd to help finance global clinical trials. Alpha Tau said it has successfully completed its first-in-human clinical trial of Alpha DaRT — a radiation cancer therapy — with squamous cell carcinoma patients from Italy and Israel. It is now conducting trials in other sites, such as its first U.S. trial at Memorial Sloan Kettering Cancer Center in New York, a pancreatic cancer trial at CHUM in Montreal and trials at three academic institutions in Japan. The company, it said, is also establishing new manu

Alpha Tau Medical Announces Successful Completion of New $26 Million Funding Round

Tel Aviv, Israel, June 4, 2020 - Alpha Tau Medical, the developer of breakthrough alpha-radiation cancer therapy Alpha DaRT, is pleased to announce the closing of a Series B equity financing of $26 million. Investors in the round included a mix of existing investors from previous rounds, such as Shavit Capital, Medison Ventures, and OurCrowd, who continue to demonstrate support for the clinical development of Alpha DaRT, as well as a number of new private and family office investors, primarily from Israel and North America. During the last year, Alpha Tau successfully completed its first-in-human clinical trial of Alpha DaRT with squamous cell carcinoma patients from Italy and Israel. The im

Lela’s Story of her Cancer Treatment Journey that Brought her to Alpha DaRT

Introduction When 78-year-old Israeli cancer patient Lela Parnes stumbled upon the Alpha DaRT treatment in 2017, with information from a friend of hers, she had just received her third diagnosis of cancer in multiple organs, as part of a long journey that had started in 2013. Lela’s Cancer Treatment Journey Lela had first been diagnosed with cancer in 2013, as a pensionaire enjoying life with her 4 children and 9 grandchildren. Back then, a tumor was detected on her right kidney. After participating in a clinical trial for an experimental therapy that failed, she had her kidney removed. Only a few months after her surgery, another tumor was detected in her right lung and in her hip bones. Th

Alpha Tau

Looking for clinical trials?

  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon